menu search

Biogen's stock falls 3.7% on earnings miss, says it brought in $1 million in sales of alzheimer's drug in the fourth quarter

Shares of Biogen Inc. BIIB, -1.92% were down 3.7% in premarket trading on Thursday after missing earnings and revenue expectations in the final quarte...

February 3, 2022, 7:45 am

Biogen's stock falls 3.7% on earnings miss, says it brought in $1 million in sales of alzheimer's drug in the fourth quarter

Shares of Biogen Inc. BIIB, -1.92% were down 3.7% in premarket trading on Thursday after missing earnings and revenue expectations in the final quarte...

February 3, 2022, 7:45 am

Biogen's stock falls 3.7% on earnings miss, says it brought in $1 million in sales of alzheimer's drug in the fourth quarter

Shares of Biogen Inc. BIIB, -1.92% were down 3.7% in premarket trading on Thursday after missing earnings and revenue expectations in the final quarte...

February 3, 2022, 7:45 am

Hapbee technologies closes second and final tranche of its previously announced upsized non-brokered private placement which raised total gross proceeds of $7,685,057

Hapbee Technologies Inc (TSX-V:HAPB, OTCQB:HAPBF) has announced the closing of the second and final tranche of its previously announced upsized non-br...

January 31, 2022, 10:03 am

Hapbee technologies closes second and final tranche of its previously announced upsized non-brokered private placement which raised total gross proceeds of $7,685,057

Hapbee Technologies Inc (TSX-V:HAPB, OTCQB:HAPBF) has announced the closing of the second and final tranche of its previously announced upsized non-br...

January 31, 2022, 10:03 am

Hapbee technologies closes second and final tranche of its previously announced upsized non-brokered private placement which raised total gross proceeds of $7,685,057

Hapbee Technologies Inc (TSX-V:HAPB, OTCQB:HAPBF) has announced the closing of the second and final tranche of its previously announced upsized non-br...

January 31, 2022, 10:03 am

Autoliv registers 15.8% sales decline in q4, notes margin pressure

Autoliv Inc (NYSE: ALV) reported a fourth-quarter FY21 sales decline of 15.8% year-on-year, to $2.119 billion, missing the analyst consensus of $2....

January 28, 2022, 9:10 am

Autoliv registers 15.8% sales decline in q4, notes margin pressure

Autoliv Inc (NYSE: ALV) reported a fourth-quarter FY21 sales decline of 15.8% year-on-year, to $2.119 billion, missing the analyst consensus of $2....

January 28, 2022, 9:10 am

Autoliv registers 15.8% sales decline in q4, notes margin pressure

Autoliv Inc (NYSE: ALV) reported a fourth-quarter FY21 sales decline of 15.8% year-on-year, to $2.119 billion, missing the analyst consensus of $2....

January 28, 2022, 9:10 am


Search within

Pages Search Results: